{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:47Z","timestamp":1793216567859,"version":"4.5.0"},"reference-count":79,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,6]]},"DOI":"10.18632\/oncotarget.17247","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T20:49:13Z","timestamp":1492634953000},"page":"37568-37583","source":"Crossref","is-referenced-by-count":81,"title":["Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit"],"prefix":"10.18632","volume":"8","author":[{"given":"Claudia R.","family":"Oliva","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, 35294 Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Southern Research, Birmingham, 35294 Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Langford","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, 35294 Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Suto","sequence":"additional","affiliation":[{"name":"Southern Research, Birmingham, 35294 Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Griguer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, 35294 Alabama, USA"},{"name":"Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, 35294 Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Ludwin","year":"2005","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11910-005-0047-7","article-title":"Optimal role of temozolomide in the treatment of malignant gliomas","volume":"5","author":"Hegi","year":"2005","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7150\/jca.14274","article-title":"Effect - a Consequence or the Cause of Carcinogenesis?","volume":"7","author":"Warburg","year":"2016","journal-title":"J Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Heeschen","year":"2016","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Hung","year":"2013","journal-title":"Cancer Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/15384101.2014.974419","article-title":"Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma","volume":"14","author":"Wei","year":"2015","journal-title":"Cell Cycle"},{"key":"7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","article-title":"NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism","volume":"23","author":"Machida","year":"2016","journal-title":"Cell Metab"},{"key":"8","doi-asserted-by":"crossref","first-page":"e0154576","DOI":"10.1371\/journal.pone.0154576","article-title":"Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells","volume":"11","author":"Qiu","year":"2016","journal-title":"PLoS One"},{"key":"9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ijc.25944","article-title":"Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells","volume":"129","author":"Qian","year":"2011","journal-title":"Int J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.188292.112","article-title":"Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells","volume":"26","author":"Stamenkovic","year":"2012","journal-title":"Genes Dev"},{"key":"11","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.18632\/oncotarget.3015","article-title":"Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas","volume":"6","author":"Griguer","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"39759","DOI":"10.1074\/jbc.M110.147504","article-title":"Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain","volume":"285","author":"Griguer","year":"2010","journal-title":"J Biol Chem"},{"key":"13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1\u03b1 Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells","volume":"22","author":"Sainz","year":"2015","journal-title":"Cell Metab"},{"key":"14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Becker","year":"2013","journal-title":"Cell Stem Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0167-4781(97)00025-0","article-title":"Nuclear genes for cytochrome c oxidase","volume":"1352","author":"Lomax","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0891-5849(00)00305-1","article-title":"Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase","volume":"29","author":"Bender","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"e24665","DOI":"10.1371\/journal.pone.0024665","article-title":"Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production","volume":"6","author":"Griguer","year":"2011","journal-title":"PLoS One"},{"key":"18","doi-asserted-by":"crossref","first-page":"12430","DOI":"10.1074\/jbc.M604547200","article-title":"Cytochrome C oxidase activity and oxygen tolerance","volume":"282","author":"Eaton","year":"2007","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1074\/jbc.272.15.10175","article-title":"Structural organization and promoter analysis of the bovine cytochrome c oxidase subunit VIIc gene. A functional role for YY1","volume":"272","author":"Grossman","year":"1997","journal-title":"J Biol Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1471-2407-12-273","article-title":"The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/07357900701512258","article-title":"Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials","volume":"25","author":"Ding","year":"2007","journal-title":"Cancer Invest"},{"key":"22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mito.2015.07.002","article-title":"The subunit composition and function of mammalian cytochrome c oxidase","volume":"24","author":"H\u00fcttemann","year":"2015","journal-title":"Mitochondrion"},{"key":"23","doi-asserted-by":"crossref","first-page":"e61035","DOI":"10.1371\/journal.pone.0061035","article-title":"Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme","volume":"8","author":"Oliva","year":"2013","journal-title":"PLoS One"},{"key":"24","first-page":"1013","article-title":"ATP and ADP bind to cytochrome c oxidase and regulate its activity","volume":"378","author":"Kadenbach","year":"1997","journal-title":"Biol Chem"},{"key":"25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cmet.2011.03.024","article-title":"Protein phosphorylation and prevention of cytochrome oxidase inhibition by ATP: coupled mechanisms of energy metabolism regulation","volume":"13","author":"Manfredi","year":"2011","journal-title":"Cell Metab"},{"key":"26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(98)01694-9","article-title":"The intramitochondrial ATP\/ADP-ratio controls cytochrome c oxidase activity allosterically","volume":"443","author":"Kadenbach","year":"1999","journal-title":"FEBS Lett"},{"key":"27","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1096\/fj.11-203273","article-title":"Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology","volume":"26","author":"Becker","year":"2012","journal-title":"FASEB J"},{"key":"28","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1089\/ars.2009.2692","article-title":"Adaptation to oxidative stress, chemoresistance, and cell survival","volume":"11","author":"Esposito","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"29","volume-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"Gilman","year":"1996"},{"key":"30","first-page":"CD010631","article-title":"Chlorpromazine versus atypical antipsychotic drugs for schizophrenia","volume":"4","author":"Zaman","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"31","volume-title":"WHO Model List of Essential Medicines","author":"WHO","year":"2013","edition":"18th ed"},{"key":"32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/181054a0","article-title":"Inhibiting effect of chlorpromazine on the experimental production of liver cancer","volume":"181","author":"Matsuyama","year":"1958","journal-title":"Nature"},{"key":"33","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action","volume":"67","author":"Keith","year":"2007","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"27580","DOI":"10.18632\/oncotarget.4768","article-title":"Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/CAD.0b013e32832f567b","article-title":"Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo","volume":"20","author":"Simopoulou","year":"2009","journal-title":"Anticancer Drugs"},{"key":"36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3858\/emm.2010.42.5.041","article-title":"Chlorpromazine activates p21Waf1\/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells","volume":"42","author":"Lee","year":"2010","journal-title":"Exp Mol Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Lee","year":"2013","journal-title":"Carcinogenesis"},{"key":"38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/CAD.0b013e32832ec041","article-title":"The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells","volume":"20","author":"Guerra","year":"2009","journal-title":"Anticancer Drugs"},{"key":"39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1042\/bj0720204","article-title":"The effect of chlorpromazine on the respiratory chain; cytochrome oxidase","volume":"72","author":"Rees","year":"1959","journal-title":"Biochem J"},{"key":"40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1042\/bj0730016","article-title":"The mechanism of action of chlorpromazine. Reduced diphosphopyridine nucleotidecytochrome c reductase and coupled phosphorylation","volume":"73","author":"Rees","year":"1959","journal-title":"Biochem J"},{"key":"41","unstructured":"SiteMap, Schr\u00f6dinger. New York, NY. 2015."},{"key":"42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11060-004-6404-6","article-title":"Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines","volume":"74","author":"Gillespie","year":"2005","journal-title":"J Neurooncol"},{"key":"43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000017328","article-title":"Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxidative metabolism","volume":"20","author":"Merle","year":"1998","journal-title":"Dev Neurosci"},{"key":"44","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/labinvest.3700355","article-title":"Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis","volume":"85","author":"Pollack","year":"2005","journal-title":"Lab Invest"},{"key":"45","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/0008-5472.CAN-03-1101","article-title":"Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells","volume":"64","author":"Capaldi","year":"2004","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10863-009-9267-x","article-title":"Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia","volume":"42","author":"Rossignol","year":"2010","journal-title":"J Bioenerg Biomembr"},{"key":"47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbabio.2008.04.002","article-title":"Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy","volume":"1777","author":"Jezek","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13287-015-0174-2","article-title":"Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism","volume":"6","author":"Lee","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"49","first-page":"182","article-title":"Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme","volume":"3","author":"Lin","year":"2013","journal-title":"Front Oncol"},{"key":"50","article-title":"Identification of small molecule inhibitors of human cytochrome c oxidase that target chemoresistant glioma cells","volume":"291","author":"Griguer","year":"2016","journal-title":"J Biol Chem"},{"key":"51","article-title":"Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells","volume":"10","author":"Mor","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"52","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/srep03468","article-title":"Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage","volume":"3","author":"Zhang","year":"2013","journal-title":"Sci Rep"},{"key":"53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.molmed.2004.06.005","article-title":"Mitochondria as cancer drug targets","volume":"10","author":"Hogg","year":"2004","journal-title":"Trends Mol Med"},{"key":"54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bbabio.2010.08.008","article-title":"Approaches for targeting mitochondria in cancer therapy","volume":"1807","author":"Shah","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"55","first-page":"9","article-title":"Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells","volume":"81","author":"Yancey Gillespie","year":"2007","journal-title":"J Neurooncol"},{"key":"56","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.3390\/molecules171214733","article-title":"MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway","volume":"17","author":"Liu","year":"2012","journal-title":"Molecules"},{"key":"57","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14728222.11.8.1055","article-title":"Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling","volume":"11","author":"Tronstad","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(02)85007-2","article-title":"Mitochondria and apoptosis: new therapeutic targets","volume":"85","author":"Banker","year":"2002","journal-title":"Adv Cancer Res"},{"key":"59","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/adhm.201300037","article-title":"A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing","volume":"2","author":"Fei","year":"2013","journal-title":"Adv Healthc Mater"},{"key":"60","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.addr.2009.05.010","article-title":"Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism","volume":"61","author":"Neamati","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/157489206778776952","article-title":"Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents","volume":"1","author":"Neuzil","year":"2006","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Chandel","year":"2015","journal-title":"Nat Chem Biol"},{"key":"63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/fmc.12.190","article-title":"Targeting cancer cell mitochondria as a therapeutic approach","volume":"5","author":"Huang","year":"2013","journal-title":"Future Med Chem"},{"key":"64","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1046\/j.1471-4159.1996.66041617.x","article-title":"Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria","volume":"66","author":"Clark","year":"1996","journal-title":"J Neurochem"},{"key":"65","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1074\/jbc.273.21.12753","article-title":"Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration","volume":"273","author":"Clark","year":"1998","journal-title":"J Biol Chem"},{"key":"66","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1242\/jeb.201.8.1129","article-title":"Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase","volume":"201","author":"Margreiter","year":"1998","journal-title":"J Exp Biol"},{"key":"67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3020171","article-title":"The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach","volume":"302","author":"Mazat","year":"1994","journal-title":"Biochem J"},{"key":"68","first-page":"4677","article-title":"Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252","volume":"40","author":"Cederbaum","year":"1980","journal-title":"Cancer Res"},{"key":"69","first-page":"13","article-title":"A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma","volume":"44","author":"Geller","year":"1981","journal-title":"Lab Invest"},{"key":"70","doi-asserted-by":"crossref","first-page":"e3655","DOI":"10.1371\/journal.pone.0003655","article-title":"CD133 is a marker of bioenergetic stress in human glioma","volume":"3","author":"Gillespie","year":"2008","journal-title":"PLoS One"},{"key":"71","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/0008-5472.CAN-05-3364","article-title":"Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells","volume":"66","author":"Gillespie","year":"2006","journal-title":"Cancer Res"},{"key":"72","doi-asserted-by":"crossref","first-page":"e0132823","DOI":"10.1371\/journal.pone.0132823","article-title":"Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1215\/S1152851704000821","article-title":"Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme","volume":"7","author":"James","year":"2005","journal-title":"Neuro-oncol"},{"key":"74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-008-9737-8","article-title":"Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model","volume":"92","author":"Sarkaria","year":"2009","journal-title":"J Neurooncol"},{"key":"75","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-05-2510","article-title":"Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response","volume":"12","author":"James","year":"2006","journal-title":"Clin Cancer Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1535-7163.MCT-06-0691","article-title":"Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel","volume":"6","author":"James","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"77","doi-asserted-by":"crossref","first-page":"e100054","DOI":"10.1371\/journal.pone.0100054","article-title":"Assessment of cytochrome C oxidase dysfunction in the substantia nigra\/ventral tegmental area in schizophrenia","volume":"9","author":"Melendez-Ferro","year":"2014","journal-title":"PLoS One"},{"key":"78","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbabio.2010.12.016","article-title":"A combined quantum chemical and crystallographic study on the oxidized binuclear center of cytochrome c oxidase","volume":"1807","author":"Wikstrom","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"79","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Farid","year":"2006","journal-title":"J Med Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T17:29:26Z","timestamp":1719163766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":79,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,6,6]]}},"alternative-id":["17247","28455961"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17247","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}